taurine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cystamine is beneficial to Huntington disease (HD) transgenic mice." | 7.73 | Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease. ( Cooper, AJ; Hayden, MR; Jeitner, TM; Krasnikov, BF; Leavitt, BR; Pinto, JT; Thaler, HT; Van Raamsdonk, JM, 2005) |
| "Cystamine is beneficial to Huntington disease (HD) transgenic mice." | 3.73 | Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease. ( Cooper, AJ; Hayden, MR; Jeitner, TM; Krasnikov, BF; Leavitt, BR; Pinto, JT; Thaler, HT; Van Raamsdonk, JM, 2005) |
| "Taurine pretreatment also caused about 2-fold increase in GABA concentration compared to 3-NP-treated animals." | 1.33 | Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. ( Abdel-Naim, AB; Arafa, HM; Khalifa, AE; Tadros, MG, 2005) |
| "Taurine is a sulfonic amino acid with inhibitory effects in the central nervous system." | 1.28 | Taurine treatment of dyskinesias: an attempt. ( Blom, H; Engelsen, BA; Nyland, H, 1989) |
| "Quinolinic acid (QA) is an endogenous excitotoxin present in mammalian brain that reproduces many of the histologic and neurochemical features of Huntington's disease (HD)." | 1.27 | Systemic approaches to modifying quinolinic acid striatal lesions in rats. ( Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsang, TM | 1 |
| Haselden, JN | 1 |
| Holmes, E | 1 |
| Pinto, JT | 1 |
| Van Raamsdonk, JM | 1 |
| Leavitt, BR | 1 |
| Hayden, MR | 1 |
| Jeitner, TM | 1 |
| Thaler, HT | 1 |
| Krasnikov, BF | 1 |
| Cooper, AJ | 1 |
| Tadros, MG | 1 |
| Khalifa, AE | 1 |
| Abdel-Naim, AB | 1 |
| Arafa, HM | 1 |
| Kish, SJ | 1 |
| Shannak, KS | 1 |
| Perry, TL | 2 |
| Hornykiewicz, O | 1 |
| Beal, MF | 1 |
| Kowall, NW | 1 |
| Swartz, KJ | 1 |
| Ferrante, RJ | 1 |
| Martin, JB | 1 |
| Nyland, H | 1 |
| Engelsen, BA | 1 |
| Blom, H | 1 |
| Bonilla, E | 1 |
| Prasad, AL | 1 |
| Arrieta, A | 1 |
| Hansen, S | 1 |
| Kloster, M | 1 |
8 other studies available for taurine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.
Topics: Animals; Behavior, Animal; Brain; Brain Stem; Cerebellum; Cerebral Cortex; Choline; Corpus Striatum; | 2009 |
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Colorimetry; Cystamine; Cysteamine; Female; Gl | 2005 |
Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
Topics: Animals; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Huntington Disease; Male; | 2005 |
Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum.
Topics: Amino Acids; Cerebellum; Flunitrazepam; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperi | 1983 |
Systemic approaches to modifying quinolinic acid striatal lesions in rats.
Topics: 2-Amino-5-phosphonovalerate; Allopurinol; Amino Acids; Animals; Antioxidants; Baclofen; Corpus Stria | 1988 |
Taurine treatment of dyskinesias: an attempt.
Topics: Administration, Oral; Adult; Aged; Calcinosis; Cerebral Cortex; Female; Humans; Huntington Disease; | 1989 |
Huntington's disease: studies on brain free amino acids.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Aspartic Acid; Brain; Female; gamma-Aminobutyric Acid; | 1988 |
Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Aminobutyrates; Autopsy; Basal Ganglia; Brain; Br | 1973 |